Market Place
Sourcing Support
FDA Approves Revbio`s Crucial Trial For Cranial Flap Bone Glue
28 Jan 2026 //
BUSINESSWIRE
FDA Approves RevBio`s Bone Glue for Regenerative Trials
22 Dec 2025 //
BUSINESSWIRE
Revbio Secures $2.2M NIH Grant For TETRANITE® In Spine Fractures
06 Oct 2025 //
BUSINESSWIRE
RevBio Starts 2nd UK Trial of Bone Adhesive for Skull Repair
29 May 2025 //
BUSINESSWIRE
RevBio Granted Patent For Regenerative Bone Adhesive Technology
30 Jan 2025 //
BUSINESSWIRE
RevBio Awarded a $2 Million Follow-On NIH Grant to Reduce Opioid Use
25 Oct 2023 //
BUSINESSWIRE
RevBio Awarded a $3.4M NIH Grant for Its Novel Regenerative Bone Adhesive
06 Oct 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.